维普中文期刊产品整合服务
32篇 您的检索式:作者名="Biroulet"
    题名 作者 年代 出处 被引量
1Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies显示文摘Tine Jess Christine Rungoe Laurent Peyrin–Biroulet 2012Clinical Gastroenterology and Hepatology2012,,6:11
2Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease显示文摘Laurent Peyrin–Biroulet Kiarash Khosrotehrani Fabrice Carrat Anne–Marie Bouvier Jean–Baptiste Chevaux Tabassome Simon Frank Carbonnel Jean–Frédéric Colombel Jean–Louis Dupas Philippe Godeberge Jean–Pierre Hugot Marc Lémann Stéphane Nahon Jean–Marc Sabaté 2011Gastroenterology2011,,5:3
3Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn’s Disease: Meta-Analysis of Placebo-Controlled Trials显示文摘Laurent Peyrin–Biroulet Pierre Deltenre Nicolas de Suray Julien Branche William J. Sandborn Jean–Frédéric Colombel 2008Clinical Gastroenterology and Hepatology2008,,6:3
4Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future显示文摘S. Danese J.‐F. Colombel L. Peyrin‐Biroulet P. Rutgeerts W. Reinisch 2013Aliment Pharmacol Ther2013,,9:3
5Systematic review: fertility in non‐surgically treated inflammatory bowel disease显示文摘N. Tavernier M. Fumery L. Peyrin‐Biroulet J.‐F. Colombel C. Gower‐Rousseau 2013Aliment Pharmacol Ther2013,,8:2
6Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies显示文摘Tine Jess Christine Rungoe Laurent Peyrin–Biroulet 2012Clinical Gastroenterology and Hepatology2012,,6:2
7Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease显示文摘Harry Sokol Laurent Beaugerie Marc Maynadié David Laharie Jean‐Louis Dupas Bernard Flourié Eric Lerebours Laurent Peyrin‐Biroulet Matthieu Allez Tabassome Simon Fabrice Carrat Nicole Brousse 2012Inflamm Bowel Dis2012,,11:1
8Risk of colorectal cancer in patients with ulcerative colitis: a meta - analysis of population - based cohort studies 显示文摘Jess T Rungoe C Peyrin - Biroulet 1 2012Clin Gastroenterol Hepatol2012,10,6:1
9Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study显示文摘A. Bourrier F. Carrat J.‐F. Colombel A.‐M. Bouvier V. Abitbol P. Marteau J. Cosnes T. Simon L. Peyrin‐Biroulet L. Beaugerie 2016Aliment Pharmacol Ther2016,,2:1
10561 Successive Treatment with Cyclosporine and Infliximab in Severe Ulcerative Colitis (UC)显示文摘Sarah Leblanc Matthieu Allez Philippe Seksik Bernard Flourie Harald Peeters Jean-Louis Dupas Guillaume Bouguen Laurent Peyrin Biroulet Arnaud Bourreille Olivier Dewit Yoram Bouhnik Pierre F. Michetti Stanislas Chaussade Philippe de Saussure Jean-Frederic 2009Gastroenterology2009,,5:1
11Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience显示文摘A.OUSSALAH C.LACLOTTE J.‐B.CHEVAUX M.BENSENANE A.BABOURI A.‐A.SERRE T.BOUCEKKINE X.ROBLIN M.‐A.BIGARD L.PEYRIN‐BIROULET 2008Alimentary Pharmacology & Therapeutics2008,,8:1
12The effect of immune therapy on surgical site infection following Crohn’s Disease resection显示文摘T. Serradori A. Germain M. L. Scherrer C. Ayav M. Perez B. Romain J. P. Palot S. Rohr L. Peyrin‐Biroulet L. Bresler 2013Br J Surg2013,,8:1
13Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?显示文摘Laurent Peyrin–Biroulet Aude Bressenot Wendy Kampman Clinical Gastroenterology and Hepatology0,,6:1
14Pro spective compatison of computed tomography enterogra- phy and magnetic resonance enterography for assess ment of disease activity and conplieations in ileocolonic Crohns disease显示文摘Fiorino G Bonifacio C Peyrin- Biroulet L 2011Inflamm Bowel Dis2011,17,5:1
15Systematic review with meta‐analysis: malignancies with anti‐tumour necrosis factor‐α therapy in inflammatory bowel disease显示文摘C. J. M. Williams L. Peyrin‐Biroulet A. C. Ford 2014Aliment Pharmacol Ther2014,,5:1
16Improving quality of care in inflammatory bowel disease: What changes can be made today显示文摘PanesJ 0' Connor M Peyrin - Biroulet L 2014JCC2014,8,3:1
17Long-term Outcome of Perianal Fistulizing Crohn’s Disease Treated With Infliximab显示文摘Guillaume Bouguen Laurent Siproudhis Emmanuel Gizard Timothée Wallenhorst Vincent Billioud Jean–Fran?ois Bretagne Marc–André Bigard Laurent Peyrin–Biroulet 2013Clinical Gastroenterology and Hepatology2013,,8:1
18M es-enteric fat in crohn's disease:a pathogenetic hallmark or an innocent bystander? 显示文摘Peyrin Biroulet L Chamaillard M Gonzalez F 2007Gut2007,56,4:1
19Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease 显示文摘Peyrin - Biroulet L Khosrotehrani K Carrat F 2011Gastroenterology2011,141,5:1
20Impact of mucosal healing on long‐term outcomes in ulcerative colitis treated with infliximab: a multicenter experience显示文摘D. Laharie J. Filippi X. Roblin S. Nancey J.‐B. Chevaux X. Hébuterne B. Flourié M. Capdepont L. Peyrin‐Biroulet 2013Aliment Pharmacol Ther2013,,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费